Bayesian Capital Management, LP Amgen Inc Transaction History

Bayesian Capital Management, LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $1.23 Million - $1.5 Million	4,700 Added 64.19%	12,022 $3.76 Million
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $1.97 Million - $2.38 Million	7,322 New	7,322 $2.08 Million
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $437,300 - $542,920	-2,000 Reduced 10.87%	16,400 $4.41 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $2.89 Million - $3.42 Million	13,500 Added 275.51%	18,400 $4.09 Million
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $1.11 Million - $1.35 Million	4,900 New	4,900 $1.18 Million
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $992,053 - $1.1 Million	-4,300 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $942,861 - $1.04 Million	4,300 New	4,300 $1.04 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $160,371 - $212,696	-880 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $166,504 - $214,016	880 New	880 $212,000
Q1 2019 May 14, 2019	SELL	$180.87 - $203.88 $1.79 Million - $2.02 Million	-9,900 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$178.4 - $208.25 $1.77 Million - $2.06 Million	9,900 New	9,900 $1.93 Million
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $1.73 Million - $1.94 Million	-10,400 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $1.76 Million - $2.06 Million	10,400 New	10,400 $1.77 Million

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $146B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.